Intellipharmaceutics International Inc
TSX:IPCI

Watchlist Manager
Intellipharmaceutics International Inc Logo
Intellipharmaceutics International Inc
TSX:IPCI
Watchlist
Price: 0.08 CAD Market Closed
Market Cap: 2.8m CAD

Net Margin
Intellipharmaceutics International Inc

-350.7%
Current
-1 982%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-350.7%
=
Net Income
-3.2m
/
Revenue
904.9k

Net Margin Across Competitors

No Stocks Found

Intellipharmaceutics International Inc
Glance View

Market Cap
2.6m CAD
Industry
Pharmaceuticals

Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The company is headquartered in Etobicoke, Ontario. The firm is specializing in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products and product candidates in various stages of development, in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. Its Paradoxical OverDose Resistance Activating System (PODRAS) delivery technology is designed to prevent overdose when more pills than prescribed are swallowed intact. Its product and product candidates include Generic Focalin XR, Generic Keppra XR, Generic Glucophage XR and Generic Effexor XR, among others.

IPCI Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-350.7%
=
Net Income
-3.2m
/
Revenue
904.9k
What is the Net Margin of Intellipharmaceutics International Inc?

Based on Intellipharmaceutics International Inc's most recent financial statements, the company has Net Margin of -350.7%.

Back to Top